The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
MRI has emerged as one of several urgently needed candidate disease progression biomarkers for the neurodegenerative disorder amyotrophic lateral sclerosis (ALS), not least due to its unique ability to non-invasively assess structural and functional cerebral pathology. We sought to identify the exte...
Päätekijät: | Menke, R, Proudfoot, M, Talbot, K, Turner, M |
---|---|
Aineistotyyppi: | Journal article |
Julkaistu: |
Elsevier
2017
|
Samankaltaisia teoksia
-
The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
Tekijä: R.A.L. Menke, et al.
Julkaistu: (2018-01-01) -
Imaging cerebral activity in amyotrophic lateral sclerosis
Tekijä: Proudfoot, M, et al.
Julkaistu: (2019) -
Motor system biomarkers in amyotrophic lateral sclerosis
Tekijä: Edmond, EC, et al.
Julkaistu: (2019) -
Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis.
Tekijä: Menke, R, et al.
Julkaistu: (2014) -
Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis
Tekijä: Malcolm Proudfoot, et al.
Julkaistu: (2019-01-01)